GeneReach Biotechnology Corp. (TPEX:4171)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
21.60
+0.10 (0.47%)
Jan 22, 2026, 1:30 PM CST

GeneReach Biotechnology Cash Flow Statement

Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 20202015 - 2019
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
Net Income
-148.46-118.73-166.27221.34376.62257.28
Upgrade
Depreciation & Amortization
72.7973.7368.0364.2859.2451.33
Upgrade
Other Amortization
1.261.010.860.890.770.5
Upgrade
Loss (Gain) From Sale of Assets
28.3828.171.39-1.7-0.41-0.5
Upgrade
Asset Writedown & Restructuring Costs
-1.54-----
Upgrade
Loss (Gain) From Sale of Investments
13.872.572.53.73.815.19
Upgrade
Loss (Gain) on Equity Investments
-----0.04
Upgrade
Stock-Based Compensation
2.1-----
Upgrade
Provision & Write-off of Bad Debts
-6.12-4.6521.43-1.135.061.99
Upgrade
Other Operating Activities
-2.8-1.35-66.17-65.6114.858.93
Upgrade
Change in Accounts Receivable
9.34-16.9712.04138.08-31.15-93.49
Upgrade
Change in Inventory
-1.0314.8124.5916.07-91.29-156.1
Upgrade
Change in Accounts Payable
-0.951.39-0.24-6.04-5.444.55
Upgrade
Change in Unearned Revenue
-2.43-0.55-2.84-11.4913.17-
Upgrade
Change in Other Net Operating Assets
4.34-2.63-33.99-0.733.8240.1
Upgrade
Operating Cash Flow
-31.28-23.22-38.67357.63348.99169.82
Upgrade
Operating Cash Flow Growth
---2.48%105.51%-
Upgrade
Capital Expenditures
-6.46-7.12-23.53-49.87-19.56-62.2
Upgrade
Sale of Property, Plant & Equipment
0.840.17-3.931.970.82
Upgrade
Sale (Purchase) of Intangibles
-3.86-1.34-3.82-0.59-1.36-2.67
Upgrade
Investment in Securities
59.13-62.75-221.54-3.85-
Upgrade
Other Investing Activities
1.630.84-1.02-1.48-26.61-44.85
Upgrade
Investing Cash Flow
51.28-70.21-249.91-48.01-41.7-108.9
Upgrade
Short-Term Debt Issued
-13755--51
Upgrade
Long-Term Debt Issued
----19830
Upgrade
Total Debt Issued
25413755-19881
Upgrade
Short-Term Debt Repaid
--70---2-
Upgrade
Long-Term Debt Repaid
--47.58-201.94-19.35-8.82-5.95
Upgrade
Total Debt Repaid
-303.4-117.58-201.94-19.35-10.82-5.95
Upgrade
Net Debt Issued (Repaid)
-49.419.42-146.94-19.35187.1875.05
Upgrade
Common Dividends Paid
----208.94-143.67-
Upgrade
Other Financing Activities
-0.02-15.99-68.95--0.04-
Upgrade
Financing Cash Flow
-66.733.43-215.89-228.2843.4875.05
Upgrade
Foreign Exchange Rate Adjustments
-15.95-16.5-27.373.84-1.010.69
Upgrade
Net Cash Flow
-62.68-106.5-531.8485.18349.75136.66
Upgrade
Free Cash Flow
-37.74-30.35-62.21307.76329.43107.62
Upgrade
Free Cash Flow Growth
----6.58%206.11%-
Upgrade
Free Cash Flow Margin
-17.52%-14.70%-27.59%41.03%32.55%12.56%
Upgrade
Free Cash Flow Per Share
-0.66-0.53-1.085.195.621.87
Upgrade
Cash Interest Paid
6.855.544.564.585.263.82
Upgrade
Cash Income Tax Paid
6.375.414.03117.3978.321.84
Upgrade
Levered Free Cash Flow
-85.43-68.7522.55262.91331.2546.48
Upgrade
Unlevered Free Cash Flow
-81.15-65.0426.15267.04335.1648.86
Upgrade
Change in Working Capital
9.26-3.9699.56135.88-110.9-204.95
Upgrade
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.